159 related articles for article (PubMed ID: 23748812)
1. Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results.
Rochet N; Hauswald H; Stoiber EM; Hensley FW; Becker HD; Debus J; Lindel K
Tumori; 2013; 99(2):183-90. PubMed ID: 23748812
[TBL] [Abstract][Full Text] [Related]
2. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract.
Harms W; Schraube P; Becker H; Latz D; Herth F; Fritz P; Wannenmacher M
Strahlenther Onkol; 2000 Feb; 176(2):60-6. PubMed ID: 10697652
[TBL] [Abstract][Full Text] [Related]
3. Salvage treatment with sole high-dose-rate endobronchial interventional radiotherapy (brachytherapy) for isolated endobronchial tumor recurrence in non-small-cell lung cancer patients: a 20-year experience.
Soror T; Kovács G; Fürschke V; Ismail M; Badakhshi H
Brachytherapy; 2019; 18(5):727-732. PubMed ID: 31227399
[TBL] [Abstract][Full Text] [Related]
4. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
[TBL] [Abstract][Full Text] [Related]
5. [The results of the endoluminal high-dose-rate irradiation of central non-small cell bronchial carcinomas].
Schraube P; Fritz P; Becker HD; Wannenmacher M
Strahlenther Onkol; 1993 Apr; 169(4):228-34. PubMed ID: 8387698
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis.
Hennequin C; Tredaniel J; Chevret S; Durdux C; Dray M; Manoux D; Perret M; Bonnaud G; Homasson JP; Chotin G; Hirsch A; Maylin C
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):21-7. PubMed ID: 9747815
[TBL] [Abstract][Full Text] [Related]
7. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions.
Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A
Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560
[TBL] [Abstract][Full Text] [Related]
8. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study.
Pérol M; Caliandro R; Pommier P; Malet C; Montbarbon X; Carrie C; Ardiet JM
Chest; 1997 May; 111(5):1417-23. PubMed ID: 9149603
[TBL] [Abstract][Full Text] [Related]
9. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors.
Huber RM; Fischer R; Hautmann H; Pöllinger B; Häussinger K; Wendt T
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):533-40. PubMed ID: 9231677
[TBL] [Abstract][Full Text] [Related]
10. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH
Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma.
Kawamura H; Ebara T; Katoh H; Tamaki T; Ishikawa H; Sakurai H; Nakano T
Radiat Oncol; 2012 Jul; 7():112. PubMed ID: 22824158
[TBL] [Abstract][Full Text] [Related]
12. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.
Nori D; Allison R; Kaplan B; Samala E; Osian A; Karbowitz S
Chest; 1993 Oct; 104(4):1006-11. PubMed ID: 7691481
[TBL] [Abstract][Full Text] [Related]
13. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
[TBL] [Abstract][Full Text] [Related]
14. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy for roentogenographically occult lung cancer by external beam irradiation and endobronchial high dose rate brachytherapy.
Furuta M; Tsukiyama I; Ohno T; Katano S; Yokoi K; Sawafuji M; Mori K; Tominaga K
Lung Cancer; 1999 Sep; 25(3):183-9. PubMed ID: 10512129
[TBL] [Abstract][Full Text] [Related]
16. Endobronchial brachytherapy in the treatment of malignant lung tumours.
Escobar-Sacristán JA; Granda-Orive JI; Gutiérrez Jiménez T; Delgado JM; Rodero Baños A; Saez Valls R
Eur Respir J; 2004 Sep; 24(3):348-52. PubMed ID: 15358689
[TBL] [Abstract][Full Text] [Related]
17. Thoracic volume radiation sparing following endobronchial brachytherapy: a quantitative analysis.
Bastin KT; Mehta MP; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):703-7. PubMed ID: 8384192
[TBL] [Abstract][Full Text] [Related]
18. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
[TBL] [Abstract][Full Text] [Related]
19. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
20. Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery.
Skowronek J; Piorunek T; Kanikowski M; Chicheł A; Bielęda G
Brachytherapy; 2013; 12(6):560-6. PubMed ID: 23850277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
